Burns J W & CO Inc Repligen Corp Transaction History

Burns J W & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 08, 2022	SELL	$161.19 - $257.96 $161,190 - $257,959	-1,000 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$194.77 - $324.21 $194,770 - $324,210	1,000 New	1,000 $289,000
Q2 2021 Jul 12, 2021	SELL	$165.87 - $220.95 $171,343 - $228,241	-1,033 Closed	0 $0
Q1 2021 Apr 16, 2021	BUY	$180.37 - $226.26 $186,322 - $233,726	1,033 New	1,033 $201,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Burns J W & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Burns J W & CO Inc with notifications on news.